0001015324-01-500009.txt : 20011029 0001015324-01-500009.hdr.sgml : 20011029 ACCESSION NUMBER: 0001015324-01-500009 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20011009 ITEM INFORMATION: Changes in registrant's certifying accountant ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 20011023 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VEREX LABORATORIES INC/CO CENTRAL INDEX KEY: 0000716861 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 840850695 STATE OF INCORPORATION: CO FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-11232 FILM NUMBER: 1764191 BUSINESS ADDRESS: STREET 1: 14 INVERNESS DR EAST STREET 2: BLDG D - STE 100 CITY: ENGLEWOOD STATE: CO ZIP: 80112 BUSINESS PHONE: 3037994499 MAIL ADDRESS: STREET 1: 14 INVERNESS DR. EAST STREET 2: BLDG. D, SUITE 100 CITY: ENGLEWOOD STATE: CO ZIP: 80112 8-K/A 1 v8ka.txt SECURITIES AND EXCHANGE COMMISSION WASHINGTON DC 20549 FORM 8-K/A Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report: October 9, 2001 --------------------------------- (Date of earliest event reported) VEREX LABORATORIES, INC. ----------------------------------------------------- (Exact Name of Registrant as Specified in its Charter Colorado 0-11232 84-0580695 ------------------------ --------------------- ------------------- (State of Incorporation) (Commission File No.) (I.R.S. Employer Identification No.) 14 Inverness Drive East, D-100, Englewood, Colorado 80112 ---------------------------------------------------------- (Address and Zip Code of Principal Executive Offices) Registrant's telephone number including area code: (303) 799-4499 -------------- (Not Applicable) ------------------------------------------------------------ Former name or former address, if changed since last report) VEREX LABOATORIES, INC. AMENDMENT NO.1 TO FORM 8-K/A CURRENT REPORT ITEM 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT On October 9, 2001, Verex Laboratories, Inc. (Registrant) dismissed Balukoff Lindstrom & Co., P.A. ("BL&Co.") as Registrant's principal accountant and engaged the services of KPMG LLP. BL&Co. was Registrant's auditor for the years ended June 30, 1999 and June 30,- 2000. The decision to dismiss BL&Co. was approved by unanimous written consent of the Board of Directors of the Registrant on September 18, 2001. BL&Co.'s report on the financial statements of the Registrant for the years ended June 30, 1999 and June 30, 2000 were unqualified. There have been no disagreements or reportable events between BL&Co. and Registrant on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure for the prior two years ended June 30, 1999 and June 30, 2000 and subsequent interim period through October 9, 2001 . The term "disagreement" is utilized in accordance with Item 304 of Regulation S-K. Registrant provided BL&Co. with a copy of this Current Report on Form 8-K prior to its filing with the SEC and requested that BL&Co. furnish it with a letter, addressed to the Securities and Exchange Commission, indicating that it agrees with the statements contained in this Current Report on Form 8-K and, if it does not agree, indicating the statements with which it does not agree. BL&Co. provided such letter dated October 9, 2001, stating that they agreed with the statements made in the disclosure set out in Item 4 of this Form 8-K, copy of which letter is attached hereto as Exhibit 16. ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS. Listed below are the exhibits filed as a part of this report. EXHIBITS: Exhibit Number Description Location ------- ----------- -------- 16 Amended Accountant's Letter Filed herewith electronically SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Current Report on Amendment No. 1 to Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized. (Registrant) VEREX LABORATORIES, INC. BY(Siganture) By: /s/ Patrick Bols (Date) October 23, 2001 (Name and Title) Patrick Bols, President EX-16 3 ex16.txt EXHIBIT 16 October 23, 2001 Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549 Ladies and Gentlemen: We have read and agree with the comments and changes in Item 4 of Form 8-K/A of Verex Laboratories, Inc. dated October 23, 2001 ("Form 8-K"). BY(Sigature) /s/ Balukoff Lindstrom & Co., P.A. (Name and Title) Balukoff Lindstrom & Co., P.A. Boise, Idaho